Valuation: Orion Oyj

Market Cap 14.34B 15.99B 13.21B 12B 22.71B 1,499B 23.35B 158B 63.04B 803B 60.01B 58.73B 2,539B P/E 2026 *
23.7x
P/E 2027 * 20.2x
Enterprise Value 14.22B 15.86B 13.11B 11.9B 22.53B 1,487B 23.16B 157B 62.53B 797B 59.52B 58.25B 2,518B EV / Sales 2026 *
6.75x
EV / Sales 2027 * 5.79x
Free-Float
90.18%
Yield 2026 *
1.9%
Yield 2027 * 2.25%
1 day-0.05%
1 week+2.77%
Current month+1.90%
1 month+23.37%
3 months+29.07%
6 months+51.64%
Current year+60.09%
1 week 98
Extreme 98
103.6
1 month 79.4
Extreme 79.4
103.6
Current year 62.7
Extreme 62.7
103.6
1 year 58.05
Extreme 58.05
103.6
3 years 31.86
Extreme 31.86
103.6
5 years 31.86
Extreme 31.86
103.6
10 years 22.57
Extreme 22.57
103.6
Manager TitleAgeSince
Chief Executive Officer 59 31/10/2022
Director of Finance/CFO 50 30/04/2024
Chief Operating Officer 46 31/12/2021
Director TitleAgeSince
Director/Board Member 63 21/03/2017
Director/Board Member 65 21/03/2017
Director/Board Member 66 05/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
08/08/25 Sell

Chief Operating Officer

4,000 0.0122%
04/08/25 Sell

Executive/Senior Manager

71 0.0002%
04/08/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+2.77%+75.99%+177.58% 16.06B
+1.47%+1.61%+48.15%+139.60% 1,258B
-0.71%+5.13%+48.52%+90.04% 679B
+0.05%+2.62%+34.19%+111.77% 518B
+0.17%+2.76%+44.07%+69.71% 390B
-1.04%+1.71%+69.61%+45.12% 367B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.90%+5.77%+37.60% 293B
-0.21%+0.54%+43.28%+73.48% 252B
+0.39%+1.46%+43.81%+123.80% 210B
Average -0.00%+1.17%+44.50%+92.91% 429B
Weighted average by Cap. +0.24%+1.18%+43.52%+96.82%

Financials

2026 *2027 *
Net sales 2.11B 2.35B 1.94B 1.76B 3.34B 220B 3.43B 23.26B 9.27B 118B 8.82B 8.63B 373B 2.41B 2.69B 2.22B 2.02B 3.82B 252B 3.92B 26.59B 10.6B 135B 10.09B 9.87B 427B
Net income 608M 678M 560M 509M 962M 63.52B 989M 6.7B 2.67B 34.03B 2.54B 2.49B 108B 711M 793M 655M 595M 1.13B 74.33B 1.16B 7.84B 3.13B 39.82B 2.98B 2.91B 126B
Net Debt -117M -131M -108M -98.05M -186M -12.25B -191M -1.29B -515M -6.56B -490M -480M -20.74B -377M -421M -348M -316M -598M -39.46B -615M -4.16B -1.66B -21.14B -1.58B -1.55B -66.83B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,215
Date Price Change Volume
10/11/26 €101.90 -0.29% 168,447
09/11/26 €102.20 +0.20% 99,944
06/11/26 €102.00 +0.69% 179,561
05/11/26 €101.30 -0.20% 150,779
04/11/26 €101.50 +2.37% 212,005
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
102.20EUR
Average target price
87.50EUR
Spread / Average Target
-14.38%
  1. Stock Market
  2. Stocks
  3. ORNBV Stock